Lexicon Pharmaceuticals LXRX Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's current debt?
- Lexicon Pharmaceuticals (LXRX) reported current debt of $0 in Q1 2026.
- How has Lexicon Pharmaceuticals's current debt changed year-over-year?
- Lexicon Pharmaceuticals's current debt decreased by 100.0% year-over-year, from $42.06M to $0.
- What is the long-term trend for Lexicon Pharmaceuticals's current debt?
- Over 3 years (2020 to 2025), Lexicon Pharmaceuticals's current debt has grown at a -26.7% compound annual growth rate (CAGR), from $11.65M to $4.6M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.